Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...
Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in ...
This year saw lofty highs and devastating lows for neuroscience drug developers like Bristol Myers Squibb, Eli Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback